Home / Recalls / Inventia Healthcare Limited / D-0852-2026

D-0852-2026 Class II Ongoing

Recalled by Inventia Healthcare Limited — Kalyan, N/A

FDA drug recall D-0852-2026 was initiated by Inventia Healthcare Limited on September 3, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 13567 bottles.

Recall Details

Product Type: Drugs
Report Date: September 23, 2026
Initiation Date: September 3, 2026
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 13567 bottles

Product Description

Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

U.S. Nationwide

Code Information

Batch # RISA24002; Exp Date: 04/2027